RUNX1 and acute myeloid leukemia: Consistently with the preleukemic HSPCs in vitro, sgCas9 completely depleted the expression of Cas9 in the resulting sgSsty1-sgCas9; AML1-ETO and sgSsty2-sgCas9; AML1-ETO AML cells (Supplemental Figure 4D).